KPNA2 and IMMT

  • Number of citations of the paper that reports this interaction (PMID 21988832)
  • 14
  • Data Source:
  • BioGRID (two hybrid)

KPNA2

IMMT

Gene Name karyopherin alpha 2 (RAG cohort 1, importin alpha 1) inner membrane protein, mitochondrial
Image No pdb structure
Gene Ontology Annotations Cellular Component
Molecular Function
Biological Process
Pathways
Drugs
Diseases
GWAS
Protein-Protein Interactions 104 interactors: ACTN1 ACTN4 ANKIB1 AP2B1 APOBEC1 APP ARL4A ARL5A BRCA1 BTBD2 CASP2 CCDC107 CDA CDK5RAP3 CHD3 CHEK2 CORO1B CREB3L3 CREBBP CSE1L CSNK1A1 CUL4B DCTN2 DDIT3 EP300 EPB41 FEZ2 FN1 FTH1 GART GMCL1 GRB2 H1F0 HAP1 HMG20A HNRNPC HOMER2 HOMEZ HSPA4 IFT20 IMMT INO80E ITK JUN KLC4 KPNB1 KRT18 KRT40 KRT8 LAMB2 LEF1 LZTS2 MAGED1 MAGEH1 MDFI MLH1 MORC3 MVP MYC NECAB2 NFKBIB NMNAT1 NR3C1 NUP153 NUP50 NUP62 NUTM1 PAX5 PLAG1 PNMA5 PRKD3 PTMA RAG1 RAN RANBP2 RBM48 RBPMS RECQL RELA RELB RGL2 RILP RNMT SART3 SERTAD3 SGK1 SLC2A2 SPRY1 SRPK1 TADA2A TAF3 TAF8 TANK TBPL2 TP53 TRAF1 TRIM54 TSC22D4 TXNIP UBR5 USHBP1 ZBTB7B ZC3H12A ZNF131 58 interactors: AKTIP ALB ARMCX3 ASCC2 ATXN1 BAG6 BMI1 C10orf88 C8orf33 CALM1 CCDC113 CCT5 CDC37 CHD3 CSTF2 DISC1 ECSIT EEF1A1 EP300 EXOSC10 FAM173A FEZ1 FUBP1 HAP1 HIVEP1 HJURP HMOX2 HNRNPD KDM1A KIF22 KPNA2 LRIF1 MRPL44 NDEL1 NDUFB9 NEK2 NIPSNAP3A NOS3 PDE4DIP PFDN1 PIAS4 PLA2G15 PPOX PRRC2A RER1 SDHAF2 SMN1 SNAPIN SRRT STMN4 STX5 TAF1D TK1 TNNT1 TRAF3IP1 TUBGCP3 TXNDC9 UBQLN4
Entrez ID 3838 10989
HPRD ID 02818 02658
Ensembl ID ENSG00000182481 ENSG00000132305
Uniprot IDs P52292 Q7Z726 B9A067 Q16891
PDB IDs 1EFX 1QGK 1QGR 3FEX 3FEY 4E4V
Enriched GO Terms of Interacting Partners?
Tagcloud ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
Tagcloud (Difference) ?
aggressive  aggressiveness  assembled  attempt  carcinomas  curable  diagnostics  disregarding  eic  emgd  endometrial  entities  figo  immunoreactivity  interplay  introducing  malignancy  mediator  mfe  microarrays  nucleocytoplasmic  precancerous  regimens  surgically  tmas  trp53  tumour  untreatable  uterus 
Tagcloud (Intersection) ?